AstraZeneca PLC

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza…

Drug Manufacturers - General

GB, Cambridge [HQ]

Financials

Analysts

Wall Street · Earnings · Institutional Sentiment

A comprehensive analysis section that covers unveiling insights about AstraZeneca PLC's gradings, price targets and earnings estimates.

Earnings

See the historical earnings and what wall street analysts forecasted and
forecast for future earnings.

Reported

Past Estimate Consensus

Future Estimate Consensus

EPS Revenue EBITDA EBIT SGA

All monetary values are presented in USD ($). E stands for Estimate.
FY	EPS		Revenue [mil.]		Profit [mil.]		EBITDA [mil.]		EBIT [mil.]		Expenses · SGA [mil.]
		E		E		E		E		E		E
2015	-	4.248	-	24,404	-	6,634	-	6,481	-	3,717	-	10,151
2016	-	4.216	-	22,787	-	6,586	-	6,051	-	3,471	-	9,479
2017	-	3.799	-	22,097	-	5,933	-	5,868	-	3,366	-	9,192
2018	-	3.375	-	21,961	-	5,272	-	5,832	-	3,345	-	9,135
2019	1.7000	3.587	22,090	24,362	2,155	5,602	7,165	6,469	3,387	3,710	10,362	10,134
2020	1.0700	4.182	24,384	26,377	1,335	6,531	7,016	7,005	3,198	4,017	11,848	10,972
2021	2.6000	5.184	26,617	36,424	3,196	8,098	8,371	9,673	5,162	5,548	11,693	15,151
2022	0.0776	6.717	37,417	44,430	112	10,491	7,565	11,799	1,056	6,767	15,680	18,482
2023	2.0900	7.337	44,351	45,812	3,288	11,460	9,327	12,166	3,757	6,978	18,955	19,057
2024	3.9400	8.150	46,914	52,420	5,955	12,730	14,690	13,921	9,637	7,984	14,461	21,805
2025	-	9.377	-	56,645	-	14,646	-	15,043	-	8,628	-	23,563
2026	-	10.353	-	60,074	-	2.F11X/td>	-	2.F111/td>	-	2.F111	-	2.F111
2027	-	11.510	-	63,759	-	1.F12X/td>	-	1.F121/td>	-	1.F121	-	1.F121
2028	-	12.313	-	66,727	-	0.F13X/td>	-	0.F131/td>	-	0.F131	-	0.F131

Institutional Sentiment

Wall Street · Earnings · Institutional Sentiment

The institutional sentiment measures the direction of new stock gradings
and price targets while comparing them Year-over-Year. We've limited the grading institutes to those we see as top-tier and update this data every month.

Morgan Stanley

1Y Ago:

n/a

Prev. Grade

n/a

Latest

n/a

JP Morgan Chase

1Y Ago:

n/a

Prev. Grade

n/a

Latest

n/a

Citigroup

1Y Ago:

n/a

Prev. Grade

n/a

Latest

n/a

Overall Consensus

Here we aggregate the price targets and gradings of all IBs/AMCs/Brokerage firms inside our database to draw a bigger picture.

Grading Consensus

Click to each, to see the grade

AstraZeneca PLC can't present the grade consensus distribution right now.

Price Target Consensus

Price Then

$n/a

Price Target

$n/a

Price Now

$133.40